Chiglitazar (trade name Bilessglu) is a drug for the treatment of type 2 diabetes.

[1] It is a peroxisome proliferator-activated receptor (PPAR) agonist.

In China, chiglitazar is approved for glycemic control in adult patients with type 2 diabetes when used in combination with diet and exercise.

[2] This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.